715,200 Vials of Magnesium Sulfate Recalled

The U.S. Food and Drug Administration (FDA) announced the Class III recall of magnesium sulfate injection, USP 50%, 10 g/20 mL.

The products were distributed by Hospira nationwide, as well as in Israel, Kuwait, Bahrain, United Arab Emirates, and Trinidad & Tobago.

What’s the reason for the recall? The FDA noted that the products had results that showed high pH. 

The Enforcement Report noted “the lot number may be followed by numbers from 01 to 99.”

Click here to read the report.

Hospira has launched a number of recalls in the recent past. 

--Stephanie Vaccaro

Reference:

1. U.S. Food and Drug Administration. Enforcement Report – Week of May 25, 2016. www.fda.gov. Accessed May 25, 2016.